}

FDA issues safety warning about Cantrell Drug products

03/26/2018

The FDA is alerting healthcare professionals and patients not to use drug products produced by Cantrell Drug Company of Little Rock, Arkansas, due to concerns about serious deficiencies in Cantrell’s compounding operations that put patient safety at risk. The FDA has also sought legal action to prevent the company from further producing and distributing drugs, and to recall all products currently on the market. Read the FDA safety alert.

<< return to Advocacy Updates